Visual acuity after intravitreal injection of triamcinolone acetonide in patients with diabetic macular edema

Abstract

Objective: Present study was done to assess the effect of Intravitreal injection of Triamcinolone Acetonide on visual acuity in patients with diabetic macular edema. Method : This prospective study was conducted on 30 eyes of 30 patients attending the OutPatient Department of Upgraded Department of Ophthalmology, Government Medical College and Hospital, Jammu, with macular edema due to diabetic retinopathy who received 4mg Intravitreal Triamcinolone Acetonide injection. Among these, 11 patients had baseline best corrected visual acuity of 6/60 and 19 patients had baseline best corrected visual acuity of 6/60. The change in visual acuity was followed for all cases at preopreation and at 1week,2week and at 3 months with Snellen chart. Results : Improvement in visual acuity was seen at 3 months. Of 11 patients with baseline visual acuity of 6/60, 72.7% (n=8) patients showed improvement and of 19 patients with baseline best corrected visual acuity of 6/60, 68.4% (n=13) patients showed improvement of 1-2 snellen lines at 3 months of follow up. No change in visual acuity from preoperation was seen at 1 week and at 2 weeks. Conclusion: Intravitreal injection of 4mg Triamcinolone Acetonide is beneficial as a treatment for diabetic macular edema. Our study found improvement in visual acuity of 1-2 snellen lines after intraviteal injection of Triamcinolone acetonide in patients with diabetic macular edema.